We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNA
251
DELISTED
Paragon 28, Inc.
FNA
$1.65M 0.03%
131,285
+45,000
+52% +$679K
AGEN
252
Agenus
AGEN
$312M
$1.63M 0.03%
72,204
+1,500
+2% +$42.5K
CCL icon
253
PUT
Carnival Corporation Ltd
CCL
$39.4B
$1.62M 0.03%
915,000
+665,000
+266% +$11M
ALGN icon
254
Align Technology
ALGN
$12B
$1.62M 0.03%
5,300
+409
+8% +$141K
VTYX
255
DELISTED
Ventyx Biosciences
VTYX
$1.58M 0.03%
45,463
-13,000
-22% -$449K
ALCYU
256
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
$1.57M 0.03%
150,000
– –
BCYC
257
Bicycle Therapeutics
BCYC
$278M
$1.57M 0.03%
77,902
– –
LADR
258
Ladder Capital
LADR
$1.21B
$1.56M 0.03%
+152,300
New +$1.65M
RAPT
259
DELISTED
RAPT Therapeutics
RAPT
$1.56M 0.03%
11,727
-375
-3% -$61.2K
ASAN icon
260
Asana
ASAN
$2B
$1.56M 0.03%
85,000
+63,490
+295% +$1.33M
GKOS icon
261
Glaukos
GKOS
$10.1B
$1.54M 0.03%
20,471
-20,000
-49% -$1.49M
HLVX
262
DELISTED
HilleVax
HLVX
$1.54M 0.03%
114,478
+34,000
+42% +$479K
ETNB
263
DELISTED
89bio
ETNB
$1.53M 0.03%
98,838
+15,000
+18% +$252K
HYAC
264
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.53M 0.03%
+150,000
New +$1.53M
ETSY icon
265
Etsy
ETSY
$7.55B
$1.52M 0.03%
+23,500
New +$1.85M
BBIO icon
266
BridgeBio Pharma
BBIO
$16.2B
$1.51M 0.03%
+57,300
New +$1.63M
SRRK icon
267
Scholar Rock
SRRK
$6.41B
$1.51M 0.03%
212,581
+10,000
+5% +$67.2K
INSM icon
268
Insmed
INSM
$28.9B
$1.5M 0.03%
59,292
-53,000
-47% -$1.21M
LRMR icon
269
Larimar Therapeutics
LRMR
$436M
$1.5M 0.03%
378,505
+15,000
+4% +$56.7K
TMO icon
270
Thermo Fisher Scientific
TMO
$214B
$1.49M 0.03%
2,950
-5,500
-65% -$2.93M
LBPH
271
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.46M 0.03%
262,265
– –
SVRA icon
272
Savara
SVRA
$1.19B
$1.44M 0.03%
380,352
-20,000
-5% -$71.3K
VRNA
273
DELISTED
Verona Pharma
VRNA
$1.43M 0.03%
87,628
– –
OPRA
274
Opera Ltd
OPRA
$1.75B
$1.41M 0.03%
+125,000
New +$2.09M
INCY icon
275
Incyte
INCY
$24B
$1.41M 0.03%
24,349
-32,000
-57% -$2.02M
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.